These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
225 related items for PubMed ID: 17674492
1. Import and production quotas for certain List I chemicals. Interim final rule with request for comment. Drug Enforcement Administration (DEA), Justice. Fed Regist; 2007 Jul 10; 72(131):37439-53. PubMed ID: 17674492 [Abstract] [Full Text] [Related]
3. Removal of thresholds for the List I chemicals pseudoephedrine and phenylpropanolamine. Final rule. Drug Enforcement Administration, Department of Justice. Fed Regist; 2010 Jul 07; 75(129):38915-22. PubMed ID: 20608288 [Abstract] [Full Text] [Related]
5. Implementation of the Comprehensive Methamphetamine Control Act of 1996; regulation of pseudoephedrine, phenylpropanolamine, and combination ephedrine drug products and reports of certain transactions to nonregulated persons. Final rule. Drug Enforcement Administration (DEA), Justice. Fed Regist; 2002 Mar 28; 67(60):14853-62. PubMed ID: 11922057 [Abstract] [Full Text] [Related]
6. Information on foreign chain of distribution for ephedrine, pseudoephedrine, and phenylpropanolamine. Final rule. Drug Enforcement Administration (DEA), Justice. Fed Regist; 2010 Mar 05; 75(43):10168-72. PubMed ID: 20383917 [Abstract] [Full Text] [Related]
7. Self-certification and employee training of mail-order distributors of scheduled listed chemical products. Interim final rule with request for comment. Drug Enforcement Administration (DEA), Department of Justice. Fed Regist; 2011 Apr 13; 76(71):20518-24. PubMed ID: 21491808 [Abstract] [Full Text] [Related]
8. Elimination of exemptions for chemical mixtures containing the list I chemicals ephedrine and/or pseudoephedrine. Final rule. Drug Enforcement Administration (DEA), Department of Justice. Fed Regist; 2008 Jul 10; 73(133):39611-4. PubMed ID: 18850676 [Abstract] [Full Text] [Related]
9. Implementation of the Methamphetamine Production Prevention Act of 2008. Final rule. Drug Enforcement Administration (DEA), Justice. Fed Regist; 2011 Dec 01; 76(231):74696-9. PubMed ID: 22145189 [Abstract] [Full Text] [Related]
10. Exemption of chemical mixtures containing the List I chemicals ephedrine, N-methylephedrine, N-methylpseudoephedrine, norpseudoephedrine, phenylpropanolamine, and pseudoephedrine. Final rule. Drug Enforcement Administration (DEA), Justice. Fed Regist; 2003 May 01; 68(84):23195-206. PubMed ID: 12725239 [Abstract] [Full Text] [Related]
11. Implementation of the Methamphetamine Anti-Proliferation Act; thresholds for retailers and for distributors required to submit mail order reports; changes to mail order reporting requirements. Final rule. Drug Enforcement Administration (DEA), Justice. Fed Regist; 2003 Oct 07; 68(194):57799-804. PubMed ID: 14535265 [Abstract] [Full Text] [Related]
12. Implementation of the Ryan Haight Online Pharmacy Consumer Protection Act of 2008. Interim final rule with request for comments. Drug Enforcement Administration (DEA), Department of Justice. Fed Regist; 2009 Apr 06; 74(64):15595-625. PubMed ID: 19507319 [Abstract] [Full Text] [Related]
13. Control of red phosphorus, white phosphorus and hypophosphorous acid (and its salts) as list I chemicals; exclusions and waivers. Final rule. Drug Enforcement Administration (DEA), Justice. Fed Regist; 2003 Jun 24; 68(121):37411-4. PubMed ID: 12836650 [Abstract] [Full Text] [Related]
14. Restricting the sale of pseudoephedrine to prevent methamphetamine production. Colker AC. NCSL Legisbrief; 2005 Feb 24; 13(7):1-2. PubMed ID: 15726724 [No Abstract] [Full Text] [Related]
15. Control of a chemical precursor used in the illicit manufacture of fentanyl as a List I chemical. Final rule. Drug Enforcement Administration (DEA), Department of Justice. Fed Regist; 2008 Jul 25; 73(144):43355-7. PubMed ID: 18949877 [Abstract] [Full Text] [Related]
16. Exemption of chemical mixtures. Final rule. Drug Enforcement Administration (DEA), U.S. Department of Justice. Fed Regist; 2007 Mar 12; 72(47):10925-8. PubMed ID: 17450656 [Abstract] [Full Text] [Related]
17. Revision of Import and Export Requirements for Controlled Substances, Listed Chemicals, and Tableting and Encapsulating Machines, Including Changes To Implement the International Trade Data System (ITDS); Revision of Reporting Requirements for Domestic Transactions in Listed Chemicals and Tableting and Encapsulating Machines; and Technical Amendments. Final rule. Drug Enforcement Administration, Department of Justice. Fed Regist; 2016 Dec 30; 81(251):96992-7044. PubMed ID: 28068052 [Abstract] [Full Text] [Related]
18. Exemption from import/export requirements for personal medical use. Final rule. Drug Enforcement Administration (DEA), Department of Justice. Fed Regist; 2004 Sep 14; 69(177):55343-7. PubMed ID: 15366181 [Abstract] [Full Text] [Related]
19. Prescription Drug Marketing Act Pedigree Requirements; effective date and compliance policy guide; request for comment. Final rule; announcement of effective date; notice of availability; request for comment. Food and Drug Administration, HHS. Fed Regist; 2006 Jun 14; 71(114):34249-51. PubMed ID: 16795943 [Abstract] [Full Text] [Related]
20. Listed chemicals; establishment of non-regulated transactions in anhydrous hydrogen chloride. Final rule confirmation. Drug Enforcement Administration (DEA), Justice. Fed Regist; 2001 Aug 16; 66(159):42944-6. PubMed ID: 11757558 [Abstract] [Full Text] [Related] Page: [Next] [New Search]